You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

selumetinib

Showing 26 - 50 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in Canada (Paclitaxel, Carboplatin, Selumetinib)

Completed
  • Non Small Cell Lung Cancer
  • Vancouver, British Columbia, Canada
  • +3 more
Apr 6, 2020

NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Avignon, France
  • +36 more
Jul 29, 2022

Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Metastatic Breast Cancer
  • Angers, France
  • +24 more
Mar 8, 2022

Lung Cancer, Melanoma, Head and Neck Carcinoma Trial in United States (Selumetinib, MEDI4736, Tremelimumab)

Completed
  • Lung Cancer
  • +7 more
  • Selumetinib
  • +2 more
  • Chicago, Illinois
  • +5 more
Nov 15, 2019

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023

NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Aberdeen, United Kingdom
  • +24 more
Nov 2, 2021

Differentiated Thyroid Cancer Trial in Worldwide (Selumetinib, Placebo, Radioactive Iodine Therapy)

Terminated
Has Results
  • Differentiated Thyroid Cancer
  • Selumetinib
  • +2 more
  • Birmingham, Alabama
  • +44 more
Aug 27, 2019

Colorectal Tumors, Gastrointestinal Tumors, Pancreatic Tumors Trial in Nijmegen, Amsterdam (Afatinib, Selumetinib, Docetaxel)

Unknown status
  • Colorectal Neoplasms
  • +3 more
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Aug 24, 2018

NSCLC (NSCLC) Trial in Tainan, Taipei (selumetinib)

Completed
  • Non-small Cell Lung Cancer (NSCLC)
  • selumetinib
  • Tainan, Taiwan
  • +2 more
Jul 9, 2018

Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +3 more
  • Diagnostic Laboratory Biomarker Analysis
  • Selumetinib
  • Los Angeles, California
  • +71 more
Jul 19, 2019

Breast Cancer Trial in Belgium, Switzerland (fulvestrant, selumetinib)

Completed
  • Breast Cancer
  • Ghent, Belgium
  • +16 more
May 13, 2019

Malignant Tumor of Respiratory and Intrathoracic Organ Carcinoma, Advanced Lung Cancer, Recurrent Nonsmall Cell Lung Cancer

Withdrawn
  • Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma
  • +2 more
  • Selumetinib
  • +2 more
  • (no location specified)
Mar 14, 2018

Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV Trial in United Kingdom (selumetinib, gemcitabine, cisplatin)

Completed
Has Results
  • Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
  • selumetinib
  • +4 more
  • Glasgow, United Kingdom
  • +3 more
Mar 12, 2018

Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Papillary Carcinoma, Stage II Thyroid Gland Papillary Carcinoma Trial

Completed
Has Results
  • Recurrent Thyroid Gland Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Selumetinib
  • Tampa, Florida
  • +5 more
Dec 2, 2016

Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Ocular Melanoma With Extraocular Extension Trial in Canada, United

Completed
Has Results
  • Iris Melanoma
  • +5 more
  • Aurora, Colorado
  • +32 more
Jun 26, 2017

Inoperable Locally Advanced or Metastatic Biliary Tract Cancer Trial in Kashiwa Shi, Chuo Ku (Cisplatin, Gemcitabine,

Terminated
Has Results
  • Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
  • Kashiwa Shi, Chiba, Japan
  • +1 more
May 5, 2016

Biliary Tract Tumors, Cholangiocarcinoma, Gallbladder Tumors Trial in London, Manchester (selumetinib, gemcitabine, cisplatin)

Completed
  • Biliary Tract Neoplasms
  • +2 more
  • selumetinib
  • +2 more
  • London, United Kingdom
  • +2 more
May 11, 2016

Liver and Intrahepatic Biliary Tract Cancer, Recurrent Extrahepatic Bile Duct Cancer, Unresectable Extrahepatic Bile Duct Cancer

Completed
Has Results
  • Liver and Intrahepatic Biliary Tract Cancer
  • +2 more
  • selumetinib
  • laboratory biomarker analysis
  • Tampa, Florida
  • +6 more
Mar 22, 2016

Adult Solid Tumor Trial in Baltimore (biological, other, drug)

Completed
  • Adult Solid Neoplasm
  • Cixutumumab
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jan 22, 2016

Adult Solid Tumor Trial in Boston, Charlestown, New York (Selumetinib)

Completed
Has Results
  • Adult Solid Neoplasm
  • Selumetinib
  • Boston, Massachusetts
  • +4 more
Dec 10, 2015

Solid Tumours Trial in Overland Park (Selumetinib, Moxifloxacin, selumetinib )

Completed
Has Results
  • Solid Tumours
  • Selumetinib
  • +2 more
  • Overland Park, Kansas
    Research Site
Oct 7, 2015

Recurrent Adult Diffuse Large Cell Lymphoma Trial in United States (Laboratory Biomarker Analysis, Selumetinib)

Terminated
Has Results
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Laboratory Biomarker Analysis
  • Selumetinib
  • Chicago, Illinois
  • +15 more
Jan 4, 2016

Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in United

Completed
Has Results
  • Recurrent Adult Soft Tissue Sarcoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Beverly Hills, California
  • +7 more
Sep 4, 2015

Solid Tumours Trial in Overland Park (selumetinib, itraconazole, fluconazole)

Completed
  • Solid Tumours
  • selumetinib
  • +2 more
  • Overland Park, Kansas
    Research Site
Jun 29, 2015

Solid Tumours Trial in Orlando (selumetinib)

Completed
  • Solid Tumours
  • selumetinib
  • Orlando, Florida
    Research Site
Jun 29, 2015